Citing new data, Pfizer outlined a case for booster shots, but there’s a debate over whether they’re needed.

By BY CARL ZIMMER, APOORVA MANDAVILLI, SHARON LAFRANIERE AND REBECCA ROBBINS from NYT Health https://ift.tt/3BJMLdQ